financetom
Business
financetom
/
Business
/
BCE Up 0.2% In US Premarket As Q2 Profit Rises Vs a Year Ago, But Misses Capital IQ's Forecast Targets; National Bank With First Take
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BCE Up 0.2% In US Premarket As Q2 Profit Rises Vs a Year Ago, But Misses Capital IQ's Forecast Targets; National Bank With First Take
Aug 1, 2024 5:48 AM

08:29 AM EDT, 08/01/2024 (MT Newswires) -- BCE Inc. ( BCEXF ) on Thursday reported a profit for its second quarter, but adjusted EPS of $0.78 missed Capital IQ forecast of $0.79, and operating revenues of $6.005 billion missed Capital IQ's $6.067.91 billion.

But it did reconfirm all 2024 financial guidance targets.

National Bank noted revenues came in lighter entirely due to lower Wireless product sales, while EBITDA beat due to CTS (Telecom) helped by a negative 4.1% opex driven by headcount reduction and technology-driven efficiencies. Wireline subscriber losses were worse than expected at minus 31K (versus consensus estimate of minus 10K). Wireless loading reflected a change in mix (postpaid lighter, prepaid beat) as seen last week with Rogers, while ARPU fell 1.9% as expected and blended churn jumped +20 bps to 1.47% (consensus 1.42%).

National has an Outperform rating and C$50 target on the stock.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Oncolytics Biotech Up 2.9% as Its Fourth-Quarter Loss Narrows on a One-Time Gain
Oncolytics Biotech Up 2.9% as Its Fourth-Quarter Loss Narrows on a One-Time Gain
Mar 7, 2024
04:12 PM EST, 03/07/2024 (MT Newswires) -- Oncolytics Biotech ( ONCY ) was up 2.9% in after hours Nasdaq trading after the company on Thursday said its fourth-quarter loss narrowed on a non-cash gain. The development-stage biopharmaceutical company said it lost C$3.9 million, or C$0.05, in the period, compared with a loss of C$8.6 million, or C$0.14, in the year-prior...
BioMarin Pharmaceutical Appoints Cristin Hubbard as Chief Commercial Officer
BioMarin Pharmaceutical Appoints Cristin Hubbard as Chief Commercial Officer
Mar 7, 2024
04:12 PM EST, 03/07/2024 (MT Newswires) -- BioMarin Pharmaceutical ( BMRN ) said Thursday it named Cristin Hubbard as chief commercial officer, starting May 20. BioMarin said Hubbard, who most recently served as head of global product strategy at Roche Pharma, will succeed Jeff Ajer. ...
Update: Market Chatter: Reddit to Start Pre-IPO Roadshow Monday, Plans to Price Offering March 20
Update: Market Chatter: Reddit to Start Pre-IPO Roadshow Monday, Plans to Price Offering March 20
Mar 7, 2024
04:04 PM EST, 03/07/2024 (MT Newswires) -- (Updates with Reddit declined to comment in last paragraph.) Reddit (RDDT) will begin its pre-IPO roadshow on Monday as the social media platform tries to woo an anchor investor, the Financial Times reported Thursday. Reddit plans to price its IPO on March 20 and start trading the following day, the FT said, citing...
Doman Building Materials Reports 2023 Financial Results
Doman Building Materials Reports 2023 Financial Results
Mar 7, 2024
04:14 PM EST, 03/07/2024 (MT Newswires) -- Doman Building Materials Group Ltd. ( CWXZF ) announced Thursday its fourth quarter and full year 2023 financial results for the period ending Dec. 31, 2023. For the year, consolidated revenues were $2.5 billion, compared to $3.0 billion in 2022, with the decrease largely due to the impact of lower construction materials pricing,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved